These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23994934)

  • 1. [Efficacy of actovegin in the treatment of elderly patients with vascular mild cognitive impairment].
    Mikhaĭlova NM; Selezneva ND; Kalyn IaB; Roshchina IF; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):69-76. PubMed ID: 23994934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARTEMIDA Trial (A Randomized Trial of Efficacy, 12 Months International Double-Blind Actovegin): A Randomized Controlled Trial to Assess the Efficacy of Actovegin in Poststroke Cognitive Impairment.
    Guekht A; Skoog I; Edmundson S; Zakharov V; Korczyn AD
    Stroke; 2017 May; 48(5):1262-1270. PubMed ID: 28432265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
    Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
    Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal approach to treatment of neurological complications of chronic brain ischemia.
    Tanashyan MM; Shabalina AA; Lagoda OV; Raskurazhev AA; Konovalov RN
    Ter Arkh; 2018 Dec; 90(12):61-67. PubMed ID: 30701835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.
    Rondanelli M; Opizzi A; Faliva M; Mozzoni M; Antoniello N; Cazzola R; Savarè R; Cerutti R; Grossi E; Cestaro B
    Nutr Neurosci; 2012 Mar; 15(2):46-54. PubMed ID: 22334085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral actovegin therapy in cerebrovascular insufficiency. Studies on the therapeutic value of actovegin forte dragees in elderly patients with advanced cerebrovascular insufficiency].
    Kopp H
    Fortschr Med; 1979 Feb; 97(7):307-12. PubMed ID: 437665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
    Derev'yannykh EA; Bel'skaya GN; Knoll EA; Krylova LG; Popov DV
    Neurosci Behav Physiol; 2008 Oct; 38(8):873-5. PubMed ID: 18802768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clock Drawing Test and the diagnosis of amnestic mild cognitive impairment: can more detailed scoring systems do the work?
    Rubínová E; Nikolai T; Marková H; Siffelová K; Laczó J; Hort J; Vyhnálek M
    J Clin Exp Neuropsychol; 2014; 36(10):1076-83. PubMed ID: 25486502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional improvement of the aging brain: placebo controlled pharmaco-EEG and psychometric studies with a metabolically active hemoderivative (Actovegin)].
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Z Gerontol; 1984; 17(5):271-9. PubMed ID: 6395527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the effects of vinpocetin on cognitive functions].
    Valikovics A; Csányi A; Németh L
    Ideggyogy Sz; 2012 Mar; 65(3-4):115-20. PubMed ID: 23136730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methods of augmentation of antidepressant therapy (on the model of complex therapy with the inclusion of actovegin) in gerontopsychiatric hospital].
    Safarova TP; Yakovleva OB; Sheshenin VS; Gavrilova SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(6. Vyp. 2):55-63. PubMed ID: 30346435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of subjective memory complaints on quality of life in community-dwelling older adults.
    Maki Y; Yamaguchi T; Yamagami T; Murai T; Hachisuka K; Miyamae F; Ito K; Awata S; Ura C; Takahashi R; Yamaguchi H
    Psychogeriatrics; 2014 Sep; 14(3):175-81. PubMed ID: 25142381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs.
    Mossello E; Pieraccioli M; Nesti N; Bulgaresi M; Lorenzi C; Caleri V; Tonon E; Cavallini MC; Baroncini C; Di Bari M; Baldasseroni S; Cantini C; Biagini CA; Marchionni N; Ungar A
    JAMA Intern Med; 2015 Apr; 175(4):578-85. PubMed ID: 25730775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of actovegin in the treatment of cognitive disturbances in discirculatory encephalopathy].
    Bugrova SG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):93-5. PubMed ID: 19137664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic correction of mild cognitive impairment in patients with chronic cerebral ischemia].
    Odinak MM; Kashin AV; Ememlin AIu; Lupanov IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):25-30. PubMed ID: 23739499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities of medical correction of moderate cognitive impairment].
    Boĭko AN; Lebedeva AV; Shchukin IA; Soldatov MA; Ismailov AM; Shikhkerimov RK; Otcheskaia OV; Khozova AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):28-32. PubMed ID: 23528579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis of cognitive deficit progression in aged patients with mild cognitive impairment under prolonged therapy (a three year observation)].
    Gavrilova SI; Kolykhalov IV; Fedorova IaB; Kalyn IaB; Selezneva ND; Samorodov AV; Miasoedov SN; Boksha IS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(3):45-53. PubMed ID: 23612410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clock drawing interpretation scale (CDIS) and neuro-psychological functions in older adults with mild and moderate cognitive impairments.
    Colombo M; Vaccaro R; Vitali SF; Malnati M; Guaita A
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():39-48. PubMed ID: 19836615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.